Andrea Janikova Selected Research

Andrea Janikova Research Topics

Disease

11	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2018 - 10/2008
8	Lymphoma (Lymphomas) 01/2021 - 10/2008
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 04/2014
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2022 - 01/2018
3	Neoplasms (Cancer) 01/2020 - 04/2015
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 03/2018
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 01/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 04/2015 - 08/2011
1	COVID-19 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Fatigue 01/2019
1	Nausea 01/2019
1	Anemia 01/2019
1	Vomiting 01/2019
1	Residual Neoplasm 12/2018
1	Genomic Instability 03/2018
1	Disease Progression 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2015
1	Necrosis 04/2015
1	Bone Marrow Diseases (Bone Marrow Disease) 11/2009
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2009

Drug/Important Bio-Agent (IBA)

13	Rituximab (Mabthera)FDA Link 08/2022 - 04/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2016
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2018 - 12/2016
1	polatuzumab vedotinIBA 08/2022
1	Bendamustine Hydrochloride FDA Link 08/2022
1	TNF Receptor-Associated Factor 4IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	ruxolitinibIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	plerixafor FDA Link 01/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Cyclin D1IBA 01/2019
1	resminostatIBA 01/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2018
1	Anaplastic Lymphoma KinaseIBA 03/2018
1	NucleophosminIBA 03/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	coltuximab ravtansineIBA 01/2018
1	Procarbazine (Matulane)FDA Link 12/2016
1	Vincristine (Oncovin)FDA LinkGeneric 12/2016
1	polyhistidineIBA 04/2015
1	LigandsIBA 04/2015
1	human TNFSF10 proteinIBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	fludarabineIBA 11/2009
1	SteroidsIBA 06/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2009
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2008

Therapy/Procedure

8	Therapeutics 07/2020 - 11/2009
3	Radiotherapy 12/2016 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Cardiac Rehabilitation 01/2022
1	Transplantation 01/2020
1	Stem Cell Transplantation 01/2019
1	Immunotherapy 01/2018
1	Intravenous Administration 06/2014